Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

NFlection Therapeutics

NFlection Therapeutics
2014 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$1.4M LATEST DEAL AMOUNT
1 INVESTORS
Description

Provider of biopharmaceutical research and development services intended to focus on the treatment of neurological disorder. The company's biopharmaceutical research and development services focuses on the treatmment of growth of tumors on nerves, enabling its clients to receive treatment from Neurofibromatosis using their clinical products.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 1 Broadway, 14th Floor
  • Cambridge, MA 02141
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NFlection Therapeutics’s full profile, request a free trial.

NFlection Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 17-Jan-2017 $1.4M 00.00 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NFlection Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

NFlection Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0

NFlection Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
Michael Wootton President & Board Member
Mark De Souza Ph.D Board Member & Co-Founder

NFlection Therapeutics Board Members (4)

Name Representing Role Since Contact
Info
Corey Goodman Self Board Member 000 0000
Ketan Patel MD F-Prime Capital Partners Board Member 000 0000
Mark De Souza Ph.D Self Board Member & Co-Founder 000 0000
Michael Wootton Self President & Board Member 000 0000